Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.44 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10086906 | 1.00 | ALDH1A1 (0.54) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL9197696 | 0.85 | ALDH1A1 (0.49) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL17047628 | 0.85 | ALDH1A1 (0.45) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL20740183 | 0.81 | LMNA (0.40) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL18856002 | 0.80 | EHMT2 (0.52) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL19578400 | 0.80 | KMT2A (0.41) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL20993559 | 0.80 | KMT2A (0.41) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL19578402 | 0.80 | KMT2A (0.41) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL9885501 | 0.79 | ALDH1A1 (0.39) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A | |
| SCHEMBL28578500 | 0.79 | LMNA (0.45) | ALDH1A1EHMT2EHMT1APOBEC3GKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082772-A1 | ANTIBODY-DRUG CONJUGATE | Genahead Bio, Inc. (JP) | 2025-03-13 | — | — | US | disclosed |
| EP-4426727-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| CN-118557747-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-113039191-B | Nucleotide analogues | 奇异基因组学系统公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-4212176-A1 | ANTIBODY-DRUG CONJUGATE | Genahead Bio, Inc. (JP) | 2023-07-19 | — | — | EP | disclosed |
| CN-109912683-B | Cytotoxin molecule, conjugate, preparation method and application thereof | 杭州多禧生物科技有限公司 | 2023-01-06 | — | — | CN | disclosed |
| EP-3210627-B1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | HANGZHOU DAC BIOTECH CO LTD (CN) | 2022-12-21 | — | — | EP | disclosed |
| WO-2022078524-A4 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-12-08 | — | — | WO | disclosed |
| CN-115443134-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2022-12-06 | — | — | CN | disclosed |
| EP-3473270-B1 | ANTIBODY-DRUG CONJUGATE | GENAHEAD BIO INC (JP) | 2022-11-30 | — | — | EP | disclosed |
| WO-2022154127-A1 | COMPOUND OR SALT THEREOF, AND ANTIBODY OBTAINED THEREFROM | 味の素株式会社 | 2022-07-21 | — | — | WO | disclosed |
| WO-2022078524-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250082772-A1 | ANTIBODY-DRUG CONJUGATE | CD63, CD99, CD74 | ALDH1A1 319/4885EHMT2 3044/4885EHMT1 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.